journal article·2022-07Open access

A platinum nanourchin-based multi-enzymatic platform to disrupt mitochondrial function assisted by modulating the intracellular H2O2 homeostasis

Jiansen Huang, Yongcan Li, Lei Zhang, Jie Wang, Zhigang Xu, Yuejun Kang, Peng Xue

Biomaterials· Volume 286

Abstract

Endogenous H 2 O 2 sacrifices for diversified therapeutic reactions against tumor. However, the treatment outcome is not always satisfactory owing to the unsustainable H 2 O 2 supply from tumor microenvironment (TME). Herein, a platinum (Pt) nanourchin-based multi-enzymatic platform (referred to PGMA) is established by surface conjugation of glucose oxidase (GOx) capped with manganese carbonyl (MnCO) and loading 3-amino-1,2,4-triazole (3-AT). The mild acidic and H 2 O 2 -rich TME can render the degradation of MnCO, followed by triggering the release of CO gas, 3-AT and Mn 2+/3+ . The resultant GOx exposure initiates intratumoral glucose depletion, which is promoted by the O 2 replenishment through Pt-catalyzed decomposition of H 2 O 2 . Meanwhile, intracellular reactive oxygen species (ROS) level is elevated through Mn 2+/3+ couple-mediated Fenton-like reaction. Hence, CO release-initiated gas therapy , glucose exhaustion-induced tumor starvation and ROS-triggered chemodynamic therapy are committed to realizing a combinatorial disruption effect on mitochondrial function. Importantly, the released 3-AT can inhibit the activity of endogenous catalase , which effectively elevates the intracellular H 2 O 2 level to compensate its consumption and provides incremental reactant for cascade utilizations. Taken together, this study aims to emphasize the importance of intracellular H 2 O 2 balance during H 2 O 2 -depleted therapeutic process, and affords a prime paradigm of applying this strategy for tumor treatment via mitochondrial dysfunction.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (62)

Show source-provided references
1. American Heart Association Council on Basic Cardiovascular Sciences, G. Council on Functional, B, Translational, mitochondrial function, biology, and role in disease: a scientific statement from the american heart association10.1161/RES.0000000000000104 ↗
2. Functional mitochondria in health and disease10.3389/fendo.2017.00296 ↗
3. Mitochondrial TCA cycle metabolites control physiology and disease10.1038/s41467-019-13668-3 ↗
4. Mitochondrial dynamics and its involvement in disease10.1146/annurev-pathmechdis-012419-032711 ↗
5. Mitochondria and cancer10.1016/j.cell.2016.07.002 ↗
6. Mitochondrial metabolism and cancer10.1038/cr.2017.155 ↗
7. Comprehensive molecular characterization of mitochondrial genomes in human cancers10.1038/s41588-019-0557-x ↗
8. Targeting mitochondria metabolism for cancer therapy10.1038/nchembio.1712 ↗
9. The mitochondrion as an emerging therapeutic target in cancer10.1016/j.molmed.2019.06.009 ↗
10. Targeting mitochondria as an anticancer strategy10.1186/s40880-019-0412-6 ↗
11. Mitochondrial electron transport chain, ROS generation and uncoupling (Review)
12. Advances in nanomedicine for cancer starvation therapy10.7150/thno.38261 ↗
13. Augmenting tumor-starvation therapy by cancer cell autophagy inhibition10.1002/advs.201902847 ↗
14. Engineering of a nanosized biocatalyst for combined tumor starvation and low-temperature photothermal therapy10.1021/acsnano.8b00309 ↗
15. Glucose starvation induces mitochondrial fragmentation depending on the dynamin GTPase Dnm1/Drp1 in fission yeast10.1074/jbc.RA119.010185 ↗
16. Inhibition of glucose transporters and glutaminase synergistically impairs tumor cell growth10.1016/j.chembiol.2019.06.005 ↗
17. Glucose oxidase-instructed traceable self-oxygenation/hyperthermia dually enhanced cancer starvation therapy10.7150/thno.40439 ↗
18. Tumor-selective catalytic nanomedicine by nanocatalyst delivery10.1038/s41467-017-00424-8 ↗
19. Glucose oxidase-instructed multimodal synergistic cancer therapy10.1002/adma.202003130 ↗
20. Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment10.1039/C7CS00891K ↗
21. Biodegradable manganese-doped calcium phosphate nanotheranostics for traceable cascade reaction-enhanced anti-tumor therapy10.1021/acsnano.9b05836 ↗
22. Janus γ-Fe2O3/SiO2-based nanotheranostics for dual-modal imaging and enhanced synergistic cancer starvation/chemodynamic therapy10.1016/j.scib.2019.12.024 ↗
23. Engineering macromolecular nanocarriers for local delivery of gaseous signaling molecules10.1016/j.addr.2021.114005 ↗
24. Gas-mediated cancer bioimaging and therapy10.1021/acsnano.9b04954 ↗
25. Strategies for engineering advanced nanomedicines for gas therapy of cancer10.1093/nsr/nwaa034 ↗
26. Emerging delivery strategies of carbon monoxide for therapeutic applications: from CO gas to CO releasing nanomaterials10.1002/smll.201904382 ↗
27. Multifunctional SGQDs-CORM@HA nanosheets for bacterial eradication through cascade-activated "nanoknife" effect and photodynamic/CO gas therapy10.1016/j.biomaterials.2021.121084 ↗
28. Carbon monoxide poisoning: pathogenesis, management, and future directions of therapy10.1164/rccm.201606-1275CI ↗
29. Mesoporous polydopamine carrying manganese carbonyl responds to tumor microenvironment for multimodal imaging-guided cancer therapy10.1002/adfm.201900095 ↗
30. Carbon monoxide controllable targeted gas therapy for synergistic anti-inflammation10.1016/j.isci.2020.101483 ↗
31. A novel H2O2 generator for tumor chemotherapy-enhanced CO gas therapy10.3389/fonc.2021.738567 ↗
32. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy10.1038/s41467-019-09566-3 ↗
33. ROS in cancer therapy: the bright side of the moon10.1038/s12276-020-0384-2 ↗
34. The role of reactive oxygen species in tumor treatment and its impact on bone marrow hematopoiesis10.2174/1389450120666191021110208 ↗
35. The double-edged roles of ROS in cancer prevention and therapy10.7150/thno.56747 ↗
36. Biodegradable nanoprodrugs: “delivering” ROS to cancer cells for molecular dynamic therapy10.1002/adma.201904011 ↗
37. Recent progress of chemodynamic therapy-induced combination cancer therapy10.1016/j.nantod.2020.100946 ↗
38. Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions10.1002/anie.201805664 ↗
39. Reactive oxygen species (ROS)-based nanomedicine10.1021/acs.chemrev.8b00626 ↗
40. Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions10.1002/anie.201805664 ↗
41. Biomedicine meets Fenton chemistry10.1021/acs.chemrev.0c00977 ↗
42. A Mn(III)-sealed metal-organic framework nanosystem for redox-unlocked tumor theranostics10.1021/acsnano.9b00300 ↗
43. Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy10.1002/anie.201712027 ↗
44. Bacterial template synthesis of multifunctional nanospindles for glutathione detection and enhanced cancer-specific chemo-chemodynamic therapy10.34133/2020/9301215 ↗
45. Tumor-specific drug release and reactive oxygen species generation for cancer chemo/chemodynamic combination therapy10.1002/advs.201801986 ↗
46. An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy10.1038/s41467-020-15591-4 ↗
47. Nanozyme decorated metal–organic frameworks for enhanced photodynamic therapy10.1021/acsnano.7b07746 ↗
48. An acidity-unlocked magnetic nanoplatform enables self-boosting ROS generation through upregulation of lactate for imaging-guided highly specific chemodynamic therapy10.1002/anie.202014415 ↗
49. Two-photon supramolecular nanoplatform for ratiometric bioimaging10.1021/acs.analchem.9b01455 ↗
50. Smart nanozyme platform with activity-correlated ratiometric molecular imaging for predicting therapeutic effects10.1002/anie.202110427 ↗
51. Light-free generation of singlet oxygen through manganese-thiophene nanosystems for pH-responsive chemiluminescence imaging and tumor therapy
52. H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cells10.1021/ja511420n ↗
53. Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling
54. Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach10.1515/hsz-2017-0131 ↗
55. Bioinspired construction of a nanozyme-based H2O2 homeostasis disruptor for intensive chemodynamic therapy10.1021/jacs.9b12873 ↗
56. Mesoporous Pt nanospheres with designed pore surface as highly active electrocatalyst10.1039/C5SC03779D ↗
57. Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties10.1039/C8NR02278J ↗
58. A novel theranostic nanoplatform based on Pd@Pt-PEG-Ce6 for enhanced photodynamic therapy by modulating tumor hypoxia microenvironment10.1002/adfm.201706310 ↗
59. Illuminating platinum transportation while maximizing therapeutic efficacy by gold nanoclusters via simultaneous near-infrared-I/II imaging and glutathione scavenging10.1021/acsnano.0c05541 ↗
60. Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment10.1007/s10147-020-01666-1 ↗
61. Porous Pt nanospheres incorporated with GOx to enable synergistic oxygen-inductive starvation/electrodynamic tumor therapy10.1002/advs.202001223 ↗
62. Allyl fluorescein ethers as promising fluorescent probes for carbon monoxide imaging in living cells10.1021/acs.analchem.7b00135 ↗